Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Green Tea in Oral Leukoplakia
NCT00176566Phase 2Terminated
- Sponsor
- University of Medicine and Dentistry of New Jersey
- Start
- Sep 2003
- Primary completion
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in oral leukoplakia comparing Green Tea Lozenges with Placebo Lozenges (2 arms). Primary endpoints: Prevalence of oral leukoplakia at 3 years, Size of oral leukoplakia at 3 years and 1 more. Started Sep 2003; status: terminated.
02
Drugs
green tea extract
03
Conditions
oral leukoplakia
Beyond the preview
Go deeper on NCT00176566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00176566.